Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01663 |
| Species: | Homo sapiens |
| Position : | chr1:207851706-207940358 |
| Year: | 2025 |
| Title: | HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | hepatocellular carcinoma |
| PMID: | 40405227 |
| MONDO: | MONDO:0007256 |
| Tissue: | Liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | Huh7 |
| CVCL ID: | CVCL_0336 |
| Cell Type: | hepatocellular carcinoma cell |
| Cell Ontology ID: | CL:0000182 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | CD34 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|